Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Diagnostic applications for Lassa fever in limited-resource settings.

Emperador DM, Yimer SA, Mazzola LT, Norheim G, Kelly-Cirino C.

BMJ Glob Health. 2019 Feb 7;4(Suppl 2):e001119. doi: 10.1136/bmjgh-2018-001119. eCollection 2019.

2.

Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia.

Mihret W, Sletbakk Brusletto B, Øvstebø R, Siebke Troseid AM, Norheim G, Merid Y, Kassu A, Abebe W, Ayele S, Silamsaw Asres M, Yamuah L, Aseffa A, Petros B, Caugant DA, Brandtzaeg P.

Innate Immun. 2019 Apr;25(3):158-167. doi: 10.1177/1753425918806363.

PMID:
30894090
3.

Ample glycosylation in membrane and cell envelope proteins may explain the phenotypic diversity and virulence in the Mycobacterium tuberculosis complex.

Birhanu AG, Yimer SA, Kalayou S, Riaz T, Zegeye ED, Holm-Hansen C, Norheim G, Aseffa A, Abebe M, Tønjum T.

Sci Rep. 2019 Feb 27;9(1):2927. doi: 10.1038/s41598-019-39654-9.

4.

Genome-based transmission modelling separates imported tuberculosis from recent transmission within an immigrant population.

Ayabina D, Ronning JO, Alfsnes K, Debech N, Brynildsrud OB, Arnesen T, Norheim G, Mengshoel AT, Rykkvin R, Dahle UR, Colijn C, Eldholm V.

Microb Genom. 2018 Oct;4(10). doi: 10.1099/mgen.0.000219. Epub 2018 Sep 14.

5.

Natural immunity against capsular group X N. meningitidis following an outbreak in Togo, 2007.

Norheim G, Mueller JE, Njanpop-Lafourcade BM, Delrieu I, Findlow H, Borrow R, Xie O, Nagaputra J, Ramasamy R, Dold C, Tamekloe TA, Rollier CS, Watt H, Kere AB, Næss LM, Pollard AJ.

Vaccine. 2018 Feb 28;36(10):1297-1303. doi: 10.1016/j.vaccine.2018.01.031. Epub 2018 Feb 2.

6.

Nε- and O-Acetylation in Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains: Proteins Involved in Bioenergetics, Virulence, and Antimicrobial Resistance Are Acetylated.

Birhanu AG, Yimer SA, Holm-Hansen C, Norheim G, Aseffa A, Abebe M, Tønjum T.

J Proteome Res. 2017 Nov 3;16(11):4045-4059. doi: 10.1021/acs.jproteome.7b00429. Epub 2017 Oct 4.

7.

Comparative Proteomic Analysis of Mycobacterium tuberculosis Lineage 7 and Lineage 4 Strains Reveals Differentially Abundant Proteins Linked to Slow Growth and Virulence.

Yimer SA, Birhanu AG, Kalayou S, Riaz T, Zegeye ED, Beyene GT, Holm-Hansen C, Norheim G, Abebe M, Aseffa A, Tønjum T.

Front Microbiol. 2017 May 9;8:795. doi: 10.3389/fmicb.2017.00795. eCollection 2017.

8.

Outer membrane vesicles extracted from Neisseria meningitidis serogroup X for prevention of meningococcal disease in Africa.

Acevedo R, Zayas C, Norheim G, Fernández S, Cedré B, Aranguren Y, Cuello M, Rodriguez Y, González H, Mandiarote A, Pérez M, Hernández M, Hernández-Cedeño M, González D, Brorson SH, Rosenqvist E, Naess L, Tunheim G, Cardoso D, García L.

Pharmacol Res. 2017 Jul;121:194-201. doi: 10.1016/j.phrs.2017.04.030. Epub 2017 May 8.

PMID:
28495657
9.

Tuberculosis Outbreak in an Educational Institution in Norway.

Norheim G, Seterelv S, Arnesen TM, Mengshoel AT, Tønjum T, Rønning JO, Eldholm V.

J Clin Microbiol. 2017 May;55(5):1327-1333. doi: 10.1128/JCM.01152-16. Epub 2017 Feb 15.

10.

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP.

Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Erratum in: Lancet. 2017 Feb 4;389(10068):504. Lancet. 2017 Feb 4;389(10068):504.

11.

Immune responses of a meningococcal A + W outer membrane vesicle (OMV) vaccine with and without aluminium hydroxide adjuvant in two different mouse strains.

Tunheim G, Arnemo M, Naess LM, Norheim G, Garcia L, Cardoso D, Mandiarote A, Gonzalez D, Sinnadurai K, Fjeldheim ÅK, Bolstad K, Rosenqvist E.

APMIS. 2016 Nov;124(11):996-1003. doi: 10.1111/apm.12589. Epub 2016 Sep 20.

PMID:
27651089
12.

Ebola vaccines - Where are we?

Watle SV, Norheim G, Røttingen JA.

Hum Vaccin Immunother. 2016 Oct 2;12(10):2700-2703. doi: 10.1080/21645515.2016.1217372.

13.

Deciphering the recent phylogenetic expansion of the originally deeply rooted Mycobacterium tuberculosis lineage 7.

Yimer SA, Namouchi A, Zegeye ED, Holm-Hansen C, Norheim G, Abebe M, Aseffa A, Tønjum T.

BMC Evol Biol. 2016 Jun 30;16(1):146. doi: 10.1186/s12862-016-0715-z.

14.

Surveillance of Bacterial Meningitis, Ethiopia, 2012-2013.

Mihret W, Lema T, Merid Y, Kassu A, Abebe W, Moges B, Tenna A, Woldegebriel F, Yidnekachew M, Mekonnen W, Ahmed A, Yamuah L, Silamsaw M, Petros B, Oksnes J, Rosenqvist E, Ayele S, Aseffa A, Caugant DA, Norheim G.

Emerg Infect Dis. 2016 Jan;22(1):75-8. doi: 10.3201/eid2201.150432.

15.

Tuberculosis outbreak in Eastern Norway.

Arnesen TM, Seterelv S, Norheim G, Helgebostad SR, Mannsåker T, Ly IN, Rønning EJ, Steen TW.

Tidsskr Nor Laegeforen. 2015 Dec 15;135(23-24):2160-4. doi: 10.4045/tidsskr.14.0770. eCollection 2015 Dec 15. English, Norwegian.

16.

Stability of a Vesicular Stomatitis Virus-Vectored Ebola Vaccine.

Arnemo M, Viksmoen Watle SS, Schoultz KM, Vainio K, Norheim G, Moorthy V, Fast P, Røttingen JA, Gjøen T.

J Infect Dis. 2016 Mar 15;213(6):930-3. doi: 10.1093/infdis/jiv532. Epub 2015 Nov 12.

PMID:
26563239
17.

FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression.

Sanders H, Norheim G, Chan H, Dold C, Vipond C, Derrick JP, Pollard AJ, Maiden MC, Feavers IM.

PLoS One. 2015 Oct 14;10(10):e0140345. doi: 10.1371/journal.pone.0140345. eCollection 2015.

18.

An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity.

Norheim G, Sanders H, Mellesdal JW, Sundfør I, Chan H, Brehony C, Vipond C, Dold C, Care R, Saleem M, Maiden MC, Derrick JP, Feavers I, Pollard AJ.

PLoS One. 2015 Sep 21;10(9):e0134353. doi: 10.1371/journal.pone.0134353. eCollection 2015.

19.

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé MK, Kone S, Kuisma E, Levine MM, Mandal S, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Watson CH, Kéïta S, Kieny MP, Røttingen JA.

Lancet. 2015 Aug 29;386(9996):857-66. doi: 10.1016/S0140-6736(15)61117-5. Epub 2015 Aug 3.

PMID:
26248676
20.

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial.

Marsay L, Dold C, Green CA, Rollier CS, Norheim G, Sadarangani M, Shanyinde M, Brehony C, Thompson AJ, Sanders H, Chan H, Haworth K, Derrick JP, Feavers IM, Maiden MC, Pollard AJ.

J Infect. 2015 Sep;71(3):326-37. doi: 10.1016/j.jinf.2015.05.006. Epub 2015 May 15.

21.

Mycobacterium tuberculosis lineage 7 strains are associated with prolonged patient delay in seeking treatment for pulmonary tuberculosis in Amhara Region, Ethiopia.

Yimer SA, Norheim G, Namouchi A, Zegeye ED, Kinander W, Tønjum T, Bekele S, Mannsåker T, Bjune G, Aseffa A, Holm-Hansen C.

J Clin Microbiol. 2015 Apr;53(4):1301-9. doi: 10.1128/JCM.03566-14. Epub 2015 Feb 11.

22.

Adjuvant effects elicited by novel oligosaccharide variants of detoxified meningococcal lipopolysaccharides on Neisseria meningitidis recombinant PorA protein: a comparison in mice.

Mehta OH, Norheim G, Hoe JC, Rollier CS, Nagaputra JC, Makepeace K, Saleem M, Chan H, Ferguson DJ, Jones C, Sadarangani M, Hood DW, Feavers I, Derrick JP, Pollard AJ, Moxon ER.

PLoS One. 2014 Dec 29;9(12):e115713. doi: 10.1371/journal.pone.0115713. eCollection 2014.

23.

Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient.

Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F.

Genome Biol. 2014 Nov 7;15(11):490. doi: 10.1186/s13059-014-0490-3.

24.

Preclinical immunogenicity study of trivalent meningococcal AWX-OMV vaccines for the African meningitis belt.

Tunheim G, Naess LM, Acevedo R, Fjeldheim ÅK, Bolstad K, García L, Cardoso D, Aase A, Zayas C, González H, Rosenqvist E, Norheim G.

Vaccine. 2014 Nov 20;32(49):6631-8. doi: 10.1016/j.vaccine.2014.09.063.

PMID:
25305564
25.

Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis.

Norheim G, Sadarangani M, Omar O, Yu LM, Mølbak K, Howitz M, Olcén P, Haglund M, van der Ende A, Pollard AJ.

BMJ Open. 2014 Feb 10;4(2):e003312. doi: 10.1136/bmjopen-2013-003312.

26.

Avidity of IgG antibodies against meningococcal serogroup a polysaccharide and correlations with bactericidal activity in sera from meningitis patients and controls from Ethiopia.

Medhane M, Tunheim G, Naess LM, Mihret W, Bedru A, Norheim G, Petros B, Aseffa A, Rosenqvist E.

Scand J Immunol. 2014 Apr;79(4):267-75. doi: 10.1111/sji.12150.

27.

Neisseria meningitidis native outer membrane vesicles containing different lipopolysaccharide glycoforms as adjuvants for meningococcal and nonmeningococcal antigens.

Nagaputra JC, Rollier CS, Sadarangani M, Hoe JC, Mehta OH, Norheim G, Saleem M, Chan H, Derrick JP, Feavers I, Pollard AJ, Moxon ER.

Clin Vaccine Immunol. 2014 Feb;21(2):234-42. doi: 10.1128/CVI.00561-13. Epub 2013 Dec 18.

28.

Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X.

Micoli F, Romano MR, Tontini M, Cappelletti E, Gavini M, Proietti D, Rondini S, Swennen E, Santini L, Filippini S, Balocchi C, Adamo R, Pluschke G, Norheim G, Pollard A, Saul A, Rappuoli R, MacLennan CA, Berti F, Costantino P.

Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19077-82. doi: 10.1073/pnas.1314476110. Epub 2013 Nov 4.

29.

Preclinical immunogenicity and functional activity studies of an A+W meningococcal outer membrane vesicle (OMV) vaccine and comparisons with existing meningococcal conjugate- and polysaccharide vaccines.

Tunheim G, Arnemo M, Næss LM, Fjeldheim ÅK, Nome L, Bolstad K, Aase A, Mandiarote A, González H, González D, García L, Cardoso D, Norheim G, Rosenqvist E.

Vaccine. 2013 Dec 9;31(51):6097-106. doi: 10.1016/j.vaccine.2013.09.044. Epub 2013 Oct 10.

PMID:
24120679
30.

Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.

Xie O, Pollard AJ, Mueller JE, Norheim G.

Vaccine. 2013 Jun 12;31(27):2852-61. doi: 10.1016/j.vaccine.2013.04.036. Epub 2013 Apr 24. Review.

PMID:
23623866
31.

Characterization of size, structure and purity of serogroup X Neisseria meningitidis polysaccharide, and development of an assay for quantification of human antibodies.

Xie O, Bolgiano B, Gao F, Lockyer K, Swann C, Jones C, Delrieu I, Njanpop-Lafourcade BM, Tamekloe TA, Pollard AJ, Norheim G.

Vaccine. 2012 Aug 31;30(40):5812-23. doi: 10.1016/j.vaccine.2012.07.032. Epub 2012 Jul 24.

PMID:
22835740
32.

An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.

Norheim G, Tunheim G, Næss LM, Kristiansen PA, Caugant DA, Rosenqvist E.

Scand J Immunol. 2012 Aug;76(2):99-107. doi: 10.1111/j.1365-3083.2012.02709.x.

33.

Genetic and structural characterization of L11 lipooligosaccharide from Neisseria meningitidis serogroup A strains.

Mistretta N, Seguin D, Thiébaud J, Vialle S, Blanc F, Brossaud M, Talaga P, Norheim G, Moreau M, Rokbi B.

J Biol Chem. 2010 Jun 25;285(26):19874-83. doi: 10.1074/jbc.M110.100636. Epub 2010 Apr 26.

34.

Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Melak B, Berhanu D, Harboe M, Kolberg J, Rosenqvist E.

Clin Vaccine Immunol. 2008 May;15(5):863-71. doi: 10.1128/CVI.00252-07. Epub 2008 Mar 12.

35.

Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7.

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Alebel T, Berhanu D, Harboe M, Rosenqvist E.

Clin Vaccine Immunol. 2007 Apr;14(4):451-63. Epub 2007 Feb 14.

36.

Characterization of Neisseria meningitidis isolates from recent outbreaks in Ethiopia and comparison with those recovered during the epidemic of 1988 to 1989.

Norheim G, Rosenqvist E, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Høiby EA, Alebel T, Berhanu D, Merid Y, Harboe M, Caugant DA.

J Clin Microbiol. 2006 Mar;44(3):861-71.

38.

Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.

Norheim G, Aase A, Caugant DA, Høiby EA, Fritzsønn E, Tangen T, Kristiansen P, Heggelund U, Rosenqvist E.

Vaccine. 2005 May 31;23(29):3762-74. Epub 2005 Mar 14.

PMID:
15893613
39.

The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease.

Holst J, Feiring B, Naess LM, Norheim G, Kristiansen P, Høiby EA, Bryn K, Oster P, Costantino P, Taha MK, Alonso JM, Caugant DA, Wedege E, Aaberge IS, Rappuoli R, Rosenqvist E.

Vaccine. 2005 Mar 18;23(17-18):2202-5.

PMID:
15755595
40.

Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease.

Norheim G, Arne Høiby E, Caugant DA, Namork E, Tangen T, Fritzsønn E, Rosenqvist E.

Vaccine. 2004 Jun 2;22(17-18):2171-80.

PMID:
15149774
41.

[Meningococcal disease in Africa--epidemiology and prevention].

Norheim G, Rosenqvist E, Aavitsland P, Caugant DA.

Tidsskr Nor Laegeforen. 2000 Jun 10;120(15):1735-9. Review. Norwegian.

PMID:
10904659
42.

Influence of season and diet on liver and kidney content of essential elements and heavy metals in Svalbard reindeer.

Borch-Iohnsen B, Nilssen KJ, Norheim G.

Biol Trace Elem Res. 1996 Mar;51(3):235-47.

PMID:
8727671
43.
44.

Supplementation with wheat selenium induces a dose-dependent response in serum and urine of a Se-replete population.

Meltzer HM, Norheim G, Løken EB, Holm H.

Br J Nutr. 1992 Mar;67(2):287-94.

PMID:
1596501
45.
46.

Seasonal siderosis in female eider nesting in Svalbard.

Borch-Iohnsen B, Holm H, Jørgensen A, Norheim G.

J Comp Pathol. 1991 Jan;104(1):7-15.

PMID:
2019677
47.

The form of selenium determines the response to supplementation in a selenium replete population.

Meltzer HM, Norheim G, Bibow K, Myhre K, Holm H.

Eur J Clin Nutr. 1990 Jun;44(6):435-46.

PMID:
2387279
49.

Selenium concentrations in the human thyroid gland.

Aaseth J, Frey H, Glattre E, Norheim G, Ringstad J, Thomassen Y.

Biol Trace Elem Res. 1990 Feb;24(2):147-52.

PMID:
1702666

Supplemental Content

Loading ...
Support Center